Wang K, Wang X, Meng X, Zhang G, et al. Molecular imaging using (18)F-FDG PET/CT and circulating inflammatory and immune indicators to predict pathological response to neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB NSCLC. Ann Nucl Med 2025 May 10. doi: 10.1007/s12149-025-02057.
PMID: 40348946